Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)
This study is currently recruiting participants.
Verified April 2012 by Seoul National University Hospital
Study NCT01589380   Information provided by Seoul National University Hospital

First Received on April 29, 2012.   Last Updated on April 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Critical Stenosis of Aortic Valve
Additional conditions recognized in this trial
Aortic Valve Stenosis
Constriction, Pathologic
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Heart Valve Diseases
Pathological Conditions, Anatomical
Ventricular Outflow Obstruction
Interventions listed in this trial
Fimasartan
Placebo
Additional drug interventions recognized in this trial
Angiotensin Receptor Antagonists
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Seoul National University Hospital
Boryung Pharmaceutical Co., Ltd
Seoul National University Bundang Hospital
Severance Hospital
Korea University Anam Hospital
Korea University Guro Hospital
Chonnam National University Hospital
Samsung Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services